(Q51976721)

19 April 2018

title

Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions. (English)

1 reference

19 April 2018

author

Pedro Redondo

1

1 reference

19 April 2018

Ignacio Melero, MD-PhD

6

object named as

Ignacio Melero

1 reference

19 April 2018

author name string

Julio del Olmo

2

1 reference

19 April 2018

Ascensión López-Diaz de Cerio

3

1 reference

19 April 2018

Susana Inoges

4

1 reference

19 April 2018

Miren Marquina

5

1 reference

19 April 2018

Maurizio Bendandi

7

1 reference

19 April 2018

language of work or name

English

0 references

publication date

22 March 2007

1 reference

19 April 2018

Journal of Investigative Dermatology

published in

1 reference

19 April 2018

volume

127

1 reference

19 April 2018

issue

7

1 reference

19 April 2018

page(s)

1673-1680

1 reference

19 April 2018

https://scigraph.springernature.com/pub.10.1038/sj.jid.5700777

exact match

0 references

cites work

Imiquimod: a novel treatment for lentigo maligna

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

The role and biology of cryosurgery in the treatment of bone tumors. A review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans' cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

In situ tumor ablation creates an antigen source for the generation of antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Synergy between In situ Cryoablation and TLR9 Stimulation Results in a Highly Effective In vivo Dendritic Cell Vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Cryosurgery for oral and pharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

History of cryosurgery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Treatment of lentigo maligna

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Inflammatory changes after cryosurgery-induced necrosis in human melanoma xenografted in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Renal cryoablation: outcome at 3 years.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth: an experimental study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Cryosurgery for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Cryotherapy for breast fibroadenomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Modulating vaccine responses with dendritic cells and Toll-like receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Immunologic response to cryoablation of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Cryotherapy for liver tumors: current status, perspectives, clinical results, and review of literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Imiquimod, a topical immune response modifier, induces migration of Langerhans cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Topical imiquimod eradicates skin metastases of malignant melanoma but fails to prevent rapid lymphogenous metastatic spread

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Management of cutaneous locoregional recurrences of melanoma: a new therapeutic perspective with imiquimod

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Topical imiquimod in the treatment of metastatic melanoma to skin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Plasmacytoid dendritic cells of different origins have distinct characteristics and function: studies of lymphoid progenitors versus myeloid progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JID.5700777

7 January 2021

Identifiers

DOI

10.1038/SJ.JID.5700777

1 reference

19 April 2018

1 reference

19 April 2018